The effect of 6-year osteoporosis treatment withzoledronic 5 mg (aclasta) in comparison with 3-yeartreatment: results from the horizon-pft.
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2011-04-01
|
| Series: | Остеопороз и остеопатии |
| Online Access: | https://endojournals.ru/index.php/osteo/article/view/4132 |